These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36179986)

  • 1. Health-Related Quality of Life Following Allogeneic Hematopoietic Cell Transplantation with Omidubicel versus Umbilical Cord Blood.
    Lin C; Sajeev G; Stiff PJ; Brunstein CG; Cutler C; Sanz G; Lindemans CA; Rezvani AR; Hanna R; Koh LP; Maziarz RT; Hwang WYK; Song Y; Liu Q; Manghani R; Sivaraman S; Signorovitch J; Horwitz ME; Sung AD
    Transplant Cell Ther; 2023 Jan; 29(1):52.e1-52.e9. PubMed ID: 36179986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune Reconstitution Profiling Suggests Antiviral Protection after Transplantation with Omidubicel: A Phase 3 Substudy.
    Szabolcs P; Mazor RD; Yackoubov D; Levy S; Stiff P; Rezvani A; Hanna R; Wagner J; Keating A; Lindemans CA; Karras N; McGuirk J; Hamerschlak N; López-Torija I; Sanz G; Valcarcel D; Horwitz ME
    Transplant Cell Ther; 2023 Aug; 29(8):517.e1-517.e12. PubMed ID: 37120136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospitalization and Healthcare Resource Utilization of Omidubicel-Onlv versus Umbilical Cord Blood Transplantation for Hematologic Malignancies: Secondary Analysis from a Pivotal Phase 3 Clinical Trial.
    Majhail NS; Miller B; Dean R; Manghani R; Shin H; Sivaraman S; Maziarz RT
    Transplant Cell Ther; 2023 Dec; 29(12):749.e1-749.e5. PubMed ID: 37703995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Projected Impact of Omidubicel-onlv on Racial/Ethnic Disparities in Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Outcomes in Hematologic Malignancies.
    Khera N; Edwards ML; Song Y; Sun R; Manghani R; Shin H; Simantov R; Signorovitch J; Sivaraman S; Gergis U
    Adv Ther; 2024 Apr; 41(4):1637-1651. PubMed ID: 38427220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omidubicel vs standard myeloablative umbilical cord blood transplantation: results of a phase 3 randomized study.
    Horwitz ME; Stiff PJ; Cutler C; Brunstein C; Hanna R; Maziarz RT; Rezvani AR; Karris NA; McGuirk J; Valcarcel D; Schiller GJ; Lindemans CA; Hwang WYK; Koh LP; Keating A; Khaled Y; Hamerschlak N; Frankfurt O; Peled T; Segalovich I; Blackwell B; Wease S; Freedman LS; Galamidi-Cohen E; Sanz G
    Blood; 2021 Oct; 138(16):1429-1440. PubMed ID: 34157093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic stem cell transplantation with omidubicel in sickle cell disease.
    Parikh S; Brochstein JA; Galamidi E; Schwarzbach A; Kurtzberg J
    Blood Adv; 2021 Feb; 5(3):843-852. PubMed ID: 33560399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter Long-Term Follow-Up of Allogeneic Hematopoietic Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical Trials.
    Lin C; Schwarzbach A; Sanz J; Montesinos P; Stiff P; Parikh S; Brunstein C; Cutler C; Lindemans CA; Hanna R; Koh LP; Jagasia MH; Valcarcel D; Maziarz RT; Keating AK; Hwang WYK; Rezvani AR; Karras NA; Fernandes JF; Rocha V; Badell I; Ram R; Schiller GJ; Volodin L; Walters MC; Hamerschlak N; Cilloni D; Frankfurt O; McGuirk JP; Kurtzberg J; Sanz G; Simantov R; Horwitz ME
    Transplant Cell Ther; 2023 May; 29(5):338.e1-338.e6. PubMed ID: 36775201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased Mortality in 1-Year Survivors of Umbilical Cord Blood Transplant vs. Matched Related or Matched Unrelated Donor Transplant in Patients with Hematologic Malignancies.
    Bohannon L; Tang H; Page K; Ren Y; Jung SH; Artica A; Britt A; Islam P; Siamakpour-Reihani S; Giri V; Lew M; Kelly M; Choi T; Gasparetto C; Long G; Lopez R; Rizzieri D; Sarantopoulos S; Chao N; Horwitz M; Sung A
    Transplant Cell Ther; 2021 Aug; 27(8):669.e1-669.e8. PubMed ID: 33991725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of omidubicel on immune reconstitution and infections in cord blood transplant patients.
    De Sa H; Maziarz RT; Gandhi AP
    Expert Opin Biol Ther; 2024 Mar; 24(3):139-146. PubMed ID: 38481366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications.
    Majhail NS; Mothukuri JM; Brunstein CG; Weisdorf DJ
    Biol Blood Marrow Transplant; 2009 May; 15(5):564-73. PubMed ID: 19361748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Umbilical cord blood as a source of stem cells].
    Bojanić I; Golubić Cepulić B
    Acta Med Croatica; 2006 Jun; 60(3):215-25. PubMed ID: 16933834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of clinical outcomes between unrelated single umbilical cord blood and "ex-vivo" T-cell depleted haploidentical transplantation in children with hematological malignancies.
    Gómez-Santos C; González-Vicent M; Molina B; Deltoro N; Herrero B; Ruiz J; Pérez-Martínez A; Diaz MA
    World J Pediatr; 2021 Dec; 17(6):609-618. PubMed ID: 34590210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of decisional regret among patients who underwent allogeneic hematopoietic stem cell transplantation and associations with quality of life and clinical outcomes.
    Cusatis RN; Tecca HR; D'Souza A; Shaw BE; Flynn KE
    Cancer; 2020 Jun; 126(11):2679-2686. PubMed ID: 32154926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults.
    Holtick U; Albrecht M; Chemnitz JM; Theurich S; Skoetz N; Scheid C; von Bergwelt-Baildon M
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD010189. PubMed ID: 24748537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized Controlled Trial of Isha Kriya versus Observation to Improve Quality of Life in Hematopoietic Cell Transplantation Recipients.
    Chopra M; Naik RR; Naik R; Sahni J; Bala K; Ahlawat J; Anand A; Singh C; Jandial A; Jain A; Prakash G; Khadwal A; Malhotra P; Lad DP
    Transplant Cell Ther; 2023 Aug; 29(8):530.e1-530.e5. PubMed ID: 37192731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Centralized patient-reported outcome data collection in transplantation is feasible and clinically meaningful.
    Shaw BE; Brazauskas R; Millard HR; Fonstad R; Flynn KE; Abernethy A; Vogel J; Petroske C; Mattila D; Drexler R; Lee SJ; Horowitz MM; Rizzo JD
    Cancer; 2017 Dec; 123(23):4687-4700. PubMed ID: 28817182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Sirolimus on Immune Reconstitution Following Myeloablative Allogeneic Stem Cell Transplantation: An Ancillary Analysis of a Randomized Controlled Trial Comparing Tacrolimus/Sirolimus and Tacrolimus/Methotrexate (Blood and Marrow Transplant Clinical Trials Network/BMT CTN 0402).
    Gooptu M; Kim HT; Howard A; Choi SW; Soiffer RJ; Antin JH; Ritz J; Cutler CS
    Biol Blood Marrow Transplant; 2019 Nov; 25(11):2143-2151. PubMed ID: 31271885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liberal Versus Restrictive Red Blood Cell Transfusion Thresholds in Hematopoietic Cell Transplantation: A Randomized, Open Label, Phase III, Noninferiority Trial.
    Tay J; Allan DS; Chatelain E; Coyle D; Elemary M; Fulford A; Petrcich W; Ramsay T; Walker I; Xenocostas A; Tinmouth A; Fergusson D
    J Clin Oncol; 2020 May; 38(13):1463-1473. PubMed ID: 32083994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study.
    Cohen S; Roy J; Lachance S; Delisle JS; Marinier A; Busque L; Roy DC; Barabé F; Ahmad I; Bambace N; Bernard L; Kiss T; Bouchard P; Caudrelier P; Landais S; Larochelle F; Chagraoui J; Lehnertz B; Corneau S; Tomellini E; van Kampen JJA; Cornelissen JJ; Dumont-Lagacé M; Tanguay M; Li Q; Lemieux S; Zandstra PW; Sauvageau G
    Lancet Haematol; 2020 Feb; 7(2):e134-e145. PubMed ID: 31704264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.